Injectable or oral composition comprises azetidine derivatives, polysorbate 80, Solutol HS15 solution and optionally ethanol, propylene glycol or PEG-400 as co-solvent

摘要

Injectable or oral composition comprises azetidine derivatives (A), polysorbate 80 (polyethylene glycol monooleate), Solutol HS15 (polyethylene glycol hydroxystearate) and optionally ethanol, propylene glycol or PEG-400 as co-solvent. Injectable or oral composition comprises azetidine derivatives (A) of formula (IA) or (IB), Polysorbate 80 (polyethylene glycol monooleate), Solutol HS15 (polyethylene glycol hydroxystearate) and optionally ethanol, propylene glycol or PEG-400 as co-solvent. Ar = (hetero)aromatic (optionally substituted by 1-4C alkyl, halo, NO, CN, 1-4C alkoxy or OH). [Image].